We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $73.4B Turnover 30.34%
1-Year Est. Return 32.8%
 

Renaissance Technologies is a hedge fund firm that trades with computer models built on mathematics and statistics. It began in 1978 as Monemetrics, founded by Jim Simons, a mathematician and former Cold War codebreaker, and took its current name in 1982. The firm launched its Medallion Fund in 1988 and staffs its research with mathematicians, statisticians, physicists, astronomers and computer scientists. Medallion trades over short time spans across many asset types, and it has been closed to outside investors since 1993, open only to current and past employees and their families.

This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+32.8%
3 Year Est. Return
+177.41%
5 Year Est. Return
+184.82%
10 Year Est. Return
+833.33%
AUM
$66.5B
AUM Growth
+$7.54B
Cap. Flow
+$3.2B
Cap. Flow %
4.81%
Top 10 Hldgs %
11.06%
Holding
4,024
New
578
Increased
1,558
Reduced
1,325
Closed
537
Avg Time Held
3.2 years
Top 10 Avg Time Held
2 years
Top 20 Avg Time Held
2 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$533M
2
AAPL icon
Apple
AAPL
+$347M
3
MU icon
Micron Technology
MU
+$272M
4
LLY icon
Eli Lilly
LLY
+$232M
5
SMCI icon
Super Micro Computer
SMCI
+$185M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$472M
2
NVDA icon
NVIDIA
NVDA
+$413M
3
TSLA icon
Tesla
TSLA
+$403M
4
COIN icon
Coinbase
COIN
+$236M
5
JNJ icon
Johnson & Johnson
JNJ
+$224M

Sector Composition

Rank Sector Weight
1 Technology 19.64%
2 Healthcare 16.8%
3 Consumer Discretionary 13.04%
4 Industrials 9.65%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PLTR icon
1
Palantir
PLTR
$405B
$1.43B 2.15%
38,419,240
-1,096,069
-3% -$33.6M
2021 Q2
13 quarters
NVO icon
2
Novo Nordisk
NVO
$184B
$975M 1.47%
8,189,315
-976,059
-11% -$130M
2013 Q2
45 quarters
UTHR icon
3
United Therapeutics
UTHR
$25.2B
$772M 1.16%
2,155,392
-19,300
-0.9% -$6.52M
2013 Q2
45 quarters
AAPL icon
4
Apple
AAPL
$5.18T
$763M 1.15%
3,276,203
+1,554,759
+90% +$347M
2020 Q3
16 quarters
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$137B
$759M 1.14%
1,631,493
+65,105
+4% +$31.3M
2017 Q1
30 quarters
MSFT icon
6
Microsoft
MSFT
$3.89T
$676M 1.02%
1,571,271
+1,246,346
+384% +$533M
2024 Q2
1 quarter
VRSN icon
7
VeriSign
VRSN
$28.1B
$603M 0.91%
3,175,990
+148,294
+5% +$26.7M
2013 Q2
45 quarters
SFM icon
8
Sprouts Farmers Market
SFM
$4.8B
$490M 0.74%
4,440,644
+2,500
+0.1% +$238K
2016 Q2
33 quarters
ABNB icon
9
Airbnb
ABNB
$110B
$459M 0.69%
3,616,495
+215,090
+6% +$27.9M
2021 Q2
13 quarters
NVDA icon
10
NVIDIA
NVDA
$3.93T
$428M 0.64%
3,528,071
-3,493,719
-50% -$413M
2023 Q1
6 quarters
EXEL icon
11
Exelixis
EXEL
$16.8B
$399M 0.6%
15,359,916
+196,850
+1% +$4.89M
2016 Q3
32 quarters
FNV icon
12
Franco-Nevada
FNV
$47.7B
$390M 0.59%
3,138,549
+64,600
+2% +$8M
2014 Q1
42 quarters
CBOE icon
13
Cboe Global Markets
CBOE
$39.2B
$385M 0.58%
1,879,724
+5,000
+0.3% +$982K
2013 Q2
45 quarters
FTNT icon
14
Fortinet
FTNT
$93.5B
$383M 0.58%
4,943,162
-83,232
-2% -$5.69M
2015 Q3
36 quarters
META icon
15
Meta Platforms (Facebook)
META
$1.64T
$371M 0.56%
647,424
-398,709
-38% -$205M
2021 Q3
12 quarters
GILD icon
16
Gilead Sciences
GILD
$208B
$351M 0.53%
4,188,524
-869,074
-17% -$66.3M
2014 Q4
39 quarters
ALSN icon
17
Allison Transmission
ALSN
$10.4B
$329M 0.49%
3,423,419
-99,100
-3% -$8.5M
2013 Q3
44 quarters
MNDY icon
18
monday.com
MNDY
$3.3B
$316M 0.48%
1,138,290
+15,600
+1% +$3.86M
2021 Q4
11 quarters
DASH icon
19
DoorDash
DASH
$74.8B
$312M 0.47%
2,186,688
-601,155
-22% -$72.9M
2021 Q2
13 quarters
CME icon
20
CME Group
CME
$114B
$310M 0.47%
1,403,089
+784,500
+127% +$162M
2021 Q3
12 quarters
CORT icon
21
Corcept Therapeutics
CORT
$7.88B
$301M 0.45%
6,509,002
-403,569
-6% -$14.3M
2015 Q1
38 quarters
NFLX icon
22
Netflix
NFLX
$255B
$298M 0.45%
4,202,090
+1,485,090
+55% +$99.3M
2024 Q2
1 quarter
INCY icon
23
Incyte
INCY
$24.7B
$297M 0.45%
4,499,540
-718,797
-14% -$45.8M
2017 Q4
27 quarters
NBIX icon
24
Neurocrine Biosciences
NBIX
$16.9B
$297M 0.45%
2,574,546
+106,400
+4% +$14.6M
2018 Q4
23 quarters
WING icon
25
Wingstop
WING
$4.3B
$291M 0.44%
699,146
+96,156
+16% +$37.4M
2023 Q1
6 quarters

Similar funds

Renaissance Technologies's Q3 2024 Portfolio in Review

As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.

  • Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
  • Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
  • Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
  • Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
  • Renaissance Technologies opened 578 new positions and closed 537 in Q3 2024.
  • Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.

Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.